What are the Treatment Options for Myopia (Nearsightedness)?

Introduction
How to slow the progression of myopia
Orthokeratology, surgery, and myopia
References


Myopia (nearsightedness) is considered one of the three major visual refractive errors, with a significant increase in prevalence over the past few decades. The condition occurs when distant objects focus anteriorly to the retina. In contrast to hyperopia, which affects close vision, people with myopia can see close objects clearly, but cannot manage distant ones.

The primary goal for managing the patient with myopia is achieving clear and efficient binocular vision with good ocular health. Treatments currently used to slow the progression of myopia include spectacle lenses, contact lenses, and various pharmaceutical agents. Some patients are candidates for refractive surgery.

Myopia

Image Credit: Edgar Daniel Yanchapaxi/Shutterstock.com

How to slow the progression of myopia

Optical correction in the form of spectacles or contact lenses is often prescribed to achieve clear distance vision. Which of the two will be chosen depends on factors such as patient age, compliance, motivation, corneal physiology, and financial considerations. Individuals with myopia have prescriptions with negative numbers, with a larger value representing more severe myopia.

Accommodative effort and retinal blur can be reduced by bifocal glasses, which change the focal point for near work. Studies published to date support the suggestion that bifocal lenses can inhibit myopia development in children, though only by a small amount and in a subset of children with particular ocular characteristics.

Contact lenses have been shown to increase peripheral vision, promote outdoor activity, and provide cosmetic benefits. The potential mechanisms of action of rigid contact lenses include transient flattening of the cornea and improved retinal image quality with reduced peripheral blurring.

Recent well-designed studies with topical atropine (a non-selective muscarinic antagonist) have demonstrated clinically significant reductions in myopia progression. Pirenzepine is also a muscarinic antagonist, but this drug is less likely to produce anti-accommodative effects (namely mydriasis and cycloplegia) compared to atropine.

Orthokeratology, surgery, and myopia

Orthokeratology represents the programmed fitting of a series of contact lenses (often over weeks and months) to flatten the cornea and reduce myopia. Modern orthokeratology procedures use reverse-geometry gas-permeable lenses and are quite effective for temporarily reducing low to moderate myopia.

An overnight lens-wearing protocol (also known as overnight orthokeratology) provides an alternative to refractive surgery for many affected individuals. The onset of the refractive effect is expeditious, changes can be observable within minutes, and the result is stable 7 to 10 days after treatment. Furthermore, the procedure appears to be completely reversible on cessation of lens wear.

Since medical usage of the excimer laser was approved in 1995 to reshape the cornea, significant developments in the correction of myopia have been achieved. The excimer laser is employed to perform photorefractive keratectomy (PRK) and laser-assisted in situ keratomileusis (LASIK), which both change the cornea's shape. The laser flattens the central cornea in myopic patients to decrease its focusing power.

Cryolathe keratomileusis and automated lamellar keratoplasty (ALK) can be used for severe myopia. Cryolathe keratomileusis involves freezing a section of corneal stroma and reshaping it on a lathe to a minus power. In ALK, an automated microkeratome moves across the cornea while the corneal cap is hinged and not sutured in place.

The best candidates for such surgical interventions are patients highly motivated to achieve improved unaided visual acuity with decreased reliance on spectacles or contact lenses. It must be noted that patients undergoing myopia progression should not have refractive surgery, and the procedure should not be done before physical maturity.

Contact Lens

Image Credit: Tero Vesalainen/Shutterstock.com

Continue Reading about myopia here!

References:

  • Gwiazda J. Treatment options for myopia. Optom Vis Sci. 2009 Jun;86(6):624-8. doi: 10.1097/OPX.0b013e3181a6a225. Erratum in: Optom Vis Sci. 2009 Jul;86(7):915. PMID: 19390466; PMCID: PMC2729053.
  • Saw SM, Gazzard G, Au Eong KG, Tan DT. Myopia: attempts to arrest progression. Br J Ophthalmol. 2002 Nov;86(11):1306-11. doi: 10.1136/bjo.86.11.1306. PMID: 12386095; PMCID: PMC1771373.
  • Fredrick DR. Myopia. BMJ. 2002 May 18;324(7347):1195-9. doi: 10.1136/bmj.324.7347.1195. PMID: 12016188; PMCID: PMC1123161.
  • Aller, T. Clinical management of progressive myopia. Eye 28, 147–153 (2014). https://doi.org/10.1038/eye.2013.259
  • medschool.cuanschutz.edu. (n.d.). Department of Ophthalmology. [online] Available at: https://medschool.cuanschutz.edu/ophthalmology [Accessed 25 Jul. 2022].

Further Reading

 

Article Revisions

  • Jul 25 2022 - Article updated and expanded to offer a more detailed and comprehensive understanding of the subject matter. In addition, a table of contents with jump links was added.

Last Updated: Sep 18, 2023

Dr. Tomislav Meštrović

Written by

Dr. Tomislav Meštrović

Dr. Tomislav Meštrović is a medical doctor (MD) with a Ph.D. in biomedical and health sciences, specialist in the field of clinical microbiology, and an Assistant Professor at Croatia's youngest university - University North. In addition to his interest in clinical, research and lecturing activities, his immense passion for medical writing and scientific communication goes back to his student days. He enjoys contributing back to the community. In his spare time, Tomislav is a movie buff and an avid traveler.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Meštrović, Tomislav. (2023, September 18). What are the Treatment Options for Myopia (Nearsightedness)?. News-Medical. Retrieved on October 31, 2024 from https://www.news-medical.net/health/What-are-the-Treatment-Options-for-Myopia-(Nearsightedness).aspx.

  • MLA

    Meštrović, Tomislav. "What are the Treatment Options for Myopia (Nearsightedness)?". News-Medical. 31 October 2024. <https://www.news-medical.net/health/What-are-the-Treatment-Options-for-Myopia-(Nearsightedness).aspx>.

  • Chicago

    Meštrović, Tomislav. "What are the Treatment Options for Myopia (Nearsightedness)?". News-Medical. https://www.news-medical.net/health/What-are-the-Treatment-Options-for-Myopia-(Nearsightedness).aspx. (accessed October 31, 2024).

  • Harvard

    Meštrović, Tomislav. 2023. What are the Treatment Options for Myopia (Nearsightedness)?. News-Medical, viewed 31 October 2024, https://www.news-medical.net/health/What-are-the-Treatment-Options-for-Myopia-(Nearsightedness).aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.